| The determinants of national innovative capacity JL Furman, ME Porter, S Stern Research policy 31 (6), 899-933, 2002 | 2935 | 2002 |
| The determinants of national innovative capacity S Stern, ME Porter, JL Furman National Bureau of Economic Research Working Paper Series, 2000 | 438 | 2000 |
| Catching up or standing still?: National innovative productivity among ‘follower’countries, 1978–1999 JL Furman, R Hayes Research policy 33 (9), 1329-1354, 2004 | 366 | 2004 |
| Climbing atop the shoulders of giants: The impact of institutions on cumulative research JL Furman, S Stern American Economic Review 101 (5), 1933-63, 2011 | 340 | 2011 |
| Public & private spillovers, location and the productivity of pharmaceutical research JL Furman, MK Kyle, IM Cockburn, R Henderson National Bureau of Economic Research Working Paper Series, 2006 | 152 | 2006 |
| Academic science and the birth of industrial research laboratories in the US pharmaceutical industry JL Furman, MJ MacGarvie Journal of Economic Behavior & Organization 63 (4), 756-776, 2007 | 130* | 2007 |
| An NCI perspective on creating sustainable biospecimen resources J Vaught, J Rogers, K Myers, MD Lim, N Lockhart, H Moore, S Sawyer, ... Journal of the national cancer institute monographs 2011 (42), 1-7, 2011 | 115 | 2011 |
| Governing knowledge in the scientific community: Exploring the role of retractions in biomedicine JL Furman, K Jensen, F Murray Research Policy 41 (2), 276-290, 2012 | 111 | 2012 |
| Retractions P Azoulay, JL Furman, JL Krieger, F Murray Review of Economics and Statistics 97 (5), 1118-1136, 2015 | 70 | 2015 |
| Academic collaboration and organizational innovation: the development of research capabilities in the US pharmaceutical industry, 1927–1946 JL Furman, M MacGarvie Industrial and Corporate Change 18 (5), 929-961, 2009 | 58 | 2009 |
| Growing stem cells: the impact of federal funding policy on the US scientific frontier JL Furman, F Murray, S Stern Journal of Policy Analysis and Management 31 (3), 661-705, 2012 | 51* | 2012 |
| Firm performance and state innovation funding: Evidence from China’s Innofund program Y Wang, J Li, JL Furman Research Policy 46 (6), 1142-1161, 2017 | 49 | 2017 |
| Location and organizing strategy: Exploring the influence of location on the organization of pharmaceutical research JL Furman Advances in Strategic Management 20, 49-88, 2003 | 45 | 2003 |
| Turnarounds JL Furman, AM McGahan Managerial and Decision Economics 23 (4‐5), 283-300, 2002 | 36 | 2002 |
| UNDERSTANDING THE DRIVERS OF NATIONAL INNOVATIVE CAPACITY. JL Furman, ME Porter, S Stern Academy of Management Proceedings 2000 (1), A1-A6, 2000 | 25 | 2000 |
| Los factores impulsores de la capacidad innovadora nacional: implicaciones para España y América Latina ME Porter, JL Furman, S Stern Claves de la Economia Mundial"(Madrid: ICEX, 2000), 78-88, 2000 | 16 | 2000 |
| More for the research dollar JL Furman, F Murray, S Stern Nature 468 (7325), 757-758, 2010 | 13 | 2010 |
| Disclosure and subsequent innovation: Evidence from the patent depository library program JL Furman, M Nagler, M Watzinger National Bureau of Economic Research Working Paper Series, 2018 | 12 | 2018 |
| Po~ er ME, Stern S JL Furman The determinants of national innovation capacity 31, 899-933, 2002 | 12 | 2002 |
| Does industry matter differently in different places J Furman Evidence from four OECD countries, 2000 | 11 | 2000 |
Scott SternDavid Sarnoff Professor of Management, MITBestätigte E-Mail-Adresse bei mit.edu
